743 / 1631
•
17.5 months estimated median
response duration
•
13.9 months estimated median
progression-free survival
1. Wang M et al. N Engl J Med 2013; 369: 507-516.
Duration of response with ibrutinib
At the time of analysis (primary analysis
of progression-free survival), the median
overall survival had not been reached as
70 patients (63%) were still alive.
1
•
Estimated 58% overall survival at 18
months
1
Overall survival rate with ibrutinib